financetom
Business
financetom
/
Business
/
-- Rogers Sugar Brief: Coming Off Restriction With Sector Perform and C$6.25 Target After $100 Million Convertible Debenture Issuance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- Rogers Sugar Brief: Coming Off Restriction With Sector Perform and C$6.25 Target After $100 Million Convertible Debenture Issuance
Feb 19, 2025 11:56 AM

02:40 PM EST, 02/19/2025 (MT Newswires) --

Price: 5.45, Change: +0.03, Percent Change: +0.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Crypto Exchange Kraken is Mulling IPO in 2026: Bloomberg
Crypto Exchange Kraken is Mulling IPO in 2026: Bloomberg
Mar 7, 2025
Crypto ( CRCW ) exchange Kraken is considering an initial public offering (IPO) by the first quarter of 2026, as the company believes the regulatory environment in the U.S. has sufficiently changed to make a public listing viable, Bloomberg reported, citing people familiar with the matter. Like many other companies and executives in the digital assets industry, the exchange was...
Billionaire Winklevoss Twins-Backed Gemini Confidentially Filed for a U.S IPO: Bloomberg
Billionaire Winklevoss Twins-Backed Gemini Confidentially Filed for a U.S IPO: Bloomberg
Mar 7, 2025
Crypto ( CRCW ) exchange and custodian Gemini has confidentially filed for an initial public offering (IPO), Bloomberg reported, citing people familiar with the matter. The firm, founded by billionaire Cameron and Tyler Winklevoss, is working with Goldman Sachs ( GS ) and Citigroup ( C/PN ), the report said, noting that no final decision has been made on the...
Hims & Hers to shut down dermatology business Apostrophe
Hims & Hers to shut down dermatology business Apostrophe
Mar 7, 2025
(Reuters) -Hims & Hers Health ( HIMS ) would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to simplify its (company's) dermatology products and operations into one seamless experience, Hims & Hers said. The telehealth company, which also offers products for skin conditions such as wrinkles and fine lines, had...
Hims & Hers to shut down dermatology business Apostrophe
Hims & Hers to shut down dermatology business Apostrophe
Mar 7, 2025
March 7 (Reuters) - Hims & Hers Health ( HIMS ) would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to simplify its (company's) dermatology products and operations into one seamless experience, Hims & Hers said. The telehealth company, which also offers products for skin conditions such as wrinkles and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved